Glucagonoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: Endocrinology]] | |||
Revision as of 15:04, 12 October 2017
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Glucagonoma historical perspective |
|
Risk calculators and risk factors for Glucagonoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]
Overview
Glucagonoma was first described in 1942 by Becker. In 1966, McGavran was the first to report a case of hyperglucagonemia associated with cutaneous changes. In 1970, Wilkinson described the typical skin eruption in glucagonoma as necrolytic migratory erythema.
Historical Perspective
- In 1942, glucagonoma was first described by Becker.
- Between 1942 and 1966, many authors tried to make associations between high level of glucagon and skin eruptions.
- In 1966, The first well-documented case of glucagonoma was reported by McGavran in a female with skin lesions and glucose intolerance. The author was the first to describe a correlation between skin lesions and islet-cell tumors.[1]
- In 1970, Wilkinson described the typical skin eruption in glucagonoma as necrolytic migratory erythema.[1]
References
- ↑ 1.0 1.1 Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar A (2012). "Necrolytic migratory erythema as the first manifestation of glucagonoma". Case Rep Surg. 2012: 974210. doi:10.1155/2012/974210. PMC 3434377. PMID 22970401.